Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Firefly Neuroscience (AIFF) Net Income towards Common Stockholders (2016 - 2025)

Firefly Neuroscience has reported Net Income towards Common Stockholders over the past 15 years, most recently at -$2.7 million for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at -$2.7 million for Q4 2025, up 28.16% from a year ago — trailing twelve months through Dec 2025 was -$24.5 million (down 134.52% YoY), and the annual figure for FY2025 was -$24.5 million, down 134.52%.
  • Net Income towards Common Stockholders for Q4 2025 was -$2.7 million at Firefly Neuroscience, down from -$2.6 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for AIFF hit a ceiling of $270815.0 in Q1 2021 and a floor of -$17.3 million in Q1 2025.
  • Median Net Income towards Common Stockholders over the past 5 years was -$1.8 million (2025), compared with a mean of -$3.1 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: surged 314.36% in 2021 and later tumbled 4820.62% in 2022.
  • Firefly Neuroscience's Net Income towards Common Stockholders stood at -$1.3 million in 2021, then tumbled by 521.92% to -$8.4 million in 2022, then soared by 101.2% to $100615.0 in 2023, then plummeted by 3861.86% to -$3.8 million in 2024, then grew by 28.16% to -$2.7 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$2.7 million (Q4 2025), -$2.6 million (Q3 2025), and -$1.8 million (Q2 2025) per Business Quant data.